Nuzenio

Immunotherapy Response

Immunotherapy Response news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 12 latest news signals 10 publisher sources 100/100 entity strength

Latest news

UH Researcher Awarded NIH R01 Grant to Advance Precision Immunotherapy for Lung Cancer - John A. Burns School of MedicineJohn A. Burns School of Medicine · Sat, 08 Aug 2026 04:10:12 GMTFDA approves Replimmune’s immunotherapy for advanced melanoma - PharmaLivePharmaLive · Fri, 07 Aug 2026 13:02:22 GMTCan Diet and the Gut Microbiome Improve Immunotherapy Response? - OncodailyOncodaily · Wed, 05 Aug 2026 16:20:28 GMTLAMC2+ Epithelial Cells Drive Bladder Cancer Progression and Predict Immunotherapy Response via SERPINB3/STAT3/CD44 Axis - Wiley Online LibraryWiley Online Library · Wed, 05 Aug 2026 07:00:00 GMTCOMPASS AI Model Predicts Immunotherapy Response - Consultant360Consultant360 · Tue, 04 Aug 2026 18:20:41 GMTImmunotherapy Plus iSBRT Boosts Response in PD-L1-Negative Breast Cancer - CancerNetworkCancerNetwork · Tue, 04 Aug 2026 18:08:46 GMTTumor Mutational Burden Predicts Response to Neoadjuvant Immunotherapy - OncodailyOncodaily · Tue, 04 Aug 2026 15:35:34 GMTLiquid Biopsy Predicts Immunotherapy Benefit Within Weeks in Advanced Lung Cancer - Clinical Lab ProductsClinical Lab Products · Tue, 04 Aug 2026 14:16:33 GMT

Timeline

Sat, 08 Aug 2026 04:10:12 GMTUH Researcher Awarded NIH R01 Grant to Advance Precision Immunotherapy for Lung Cancer - John A. Burns School of Medicine
Fri, 07 Aug 2026 13:02:22 GMTFDA approves Replimmune’s immunotherapy for advanced melanoma - PharmaLive
Wed, 05 Aug 2026 16:20:28 GMTCan Diet and the Gut Microbiome Improve Immunotherapy Response? - Oncodaily
Wed, 05 Aug 2026 07:00:00 GMTLAMC2+ Epithelial Cells Drive Bladder Cancer Progression and Predict Immunotherapy Response via SERPINB3/STAT3/CD44 Axis - Wiley Online Library
Tue, 04 Aug 2026 18:20:41 GMTCOMPASS AI Model Predicts Immunotherapy Response - Consultant360
Tue, 04 Aug 2026 18:08:46 GMTImmunotherapy Plus iSBRT Boosts Response in PD-L1-Negative Breast Cancer - CancerNetwork

Related explainers

HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.AIAI stories cover models, chips, safety, regulation, products, jobs, research, and how automated systems are being used.

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Immunotherapy Response.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

10 distinct publisher/source names are currently connected to this entity page.